Cargando…

Efficacy and maintenance of rituximab treatment in non‐infectious scleritis

Detalles Bibliográficos
Autores principales:	Vergouwen, Daphne P. C., van Laar, Jan A. M., Ten Berge, Josianne C., Ramdas, Wishal D., Rothova, Aniki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292352/ https://www.ncbi.nlm.nih.gov/pubmed/34126651 http://dx.doi.org/10.1111/aos.14939

Ejemplares similares

Intravitreal aflibercept for treatment of macular oedema associated with immune recovery uveitis
por: Rothova, Aniki, et al.
Publicado: (2020)

Scleral Proteome in Noninfectious Scleritis Unravels Upregulation of Filaggrin-2 and Signs of Neovascularization
por: Vergouwen, Daphne P. C., et al.
Publicado: (2023)

Potential Biomarkers for Noninfectious Scleritis Identified by Serum and Tear Fluid Proteomics
por: Vergouwen, Daphne P.C., et al.
Publicado: (2023)

Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature
por: Ramdas, Wishal D., et al.
Publicado: (2018)

Rituximab for non-infectious Uveitis and Scleritis
por: Ng, Caleb C., et al.
Publicado: (2021)

Rhegmatogenous retinal detachment in uveitis
por: De Hoog, Joeri, et al.
Publicado: (2017)

Commentary: Rituximab in scleritis
por: Dutta Majumder, Parthopratim
Publicado: (2020)

Case series: rituximab in the treatment of refractory sight-threatening scleritis
por: van Bilsen, Kiki, et al.
Publicado: (2011)

Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy
por: ten Berge, Josianne C., et al.
Publicado: (2016)

Evaluation of pre-processing methods for tear fluid proteomics using proximity extension assays
por: Vergouwen, Daphne P. C., et al.
Publicado: (2023)

Combined Infliximab and Rituximab in Necrotising Scleritis
por: Morarji, Jiten, et al.
Publicado: (2012)

Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age‐related macular degeneration, glaucoma and cataract
por: ten Berge, Josianne C., et al.
Publicado: (2018)

Relevance of erythrocyte sedimentation rate and C-reactive protein in patients with active uveitis
por: Groen-Hakan, Fahriye, et al.
Publicado: (2018)

Refractory necrotizing scleritis successfully treated with adalimumab
por: Lawuyi, Lola E., et al.
Publicado: (2016)

Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma
por: Buchegger, Franz, et al.
Publicado: (2011)

Scleritis: Differentiating infectious from non-infectious entities
por: Murthy, Somasheila I, et al.
Publicado: (2020)

Necrotizing scleritis in a case of Vogt-Koyanagi-Harada disease
por: Sambhav, Kumar, et al.
Publicado: (2015)

Choroidal involvement in non-infectious posterior scleritis
por: Vermeirsch, Sandra, et al.
Publicado: (2021)

Subconjunctival dirofilariasis mimicking scleritis: First report from Western India
por: Sangit, Vishram A, et al.
Publicado: (2012)

Infectious scleritis: Clinical spectrum and management outcomes in India
por: Pradhan, Zia Sultan, et al.
Publicado: (2013)

Infectious Scleritis: What the ID Clinician Should Know
por: Guerrero-Wooley, Richelle L, et al.
Publicado: (2018)

Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis
por: Della Casa, Francesca, et al.
Publicado: (2022)

Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis
por: Goel, Ruchika, et al.
Publicado: (2021)

Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis
por: Di, Mengyang, et al.
Publicado: (2023)

Imaging Studies in a Case of Infectious Scleritis after Pterygium Excision
por: Nguyen, Pho, et al.
Publicado: (2012)

Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins
por: Dwojak, M, et al.
Publicado: (2015)

Rituximab therapy combined with methotrexate for severe necrotizing scleritis in a case of granulomatosis with polyangiitis
por: Murthy, Somasheila I, et al.
Publicado: (2020)

Early surgical debridement in the management of infectious scleritis after pterygium excision
por: Tittler, Ethan H., et al.
Publicado: (2012)

Recurrent scleritis as a presenting manifestation of asymptomatic occult Takayasu arteritis
por: Sureja, Nayan Patel, et al.
Publicado: (2020)

Clinical characteristics and visual outcomes in infectious scleritis: a review
por: Ramenaden, Emeline Radhika, et al.
Publicado: (2013)

Infectious Pseudomonas and Bipolaris scleritis following history of pterygium surgery
por: Abbey, Ashkan M, et al.
Publicado: (2016)

Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation
por: Riemens, Anjo, et al.
Publicado: (2012)

Clinical features and etiology of retinal vasculitis in Northern Thailand
por: Apinyawasisuk, Supanut, et al.
Publicado: (2013)

Screening for chloroquine maculopathy in populations with uncertain reliability in outcomes of automatic visual field testing
por: Kunavisarut, Paradee, et al.
Publicado: (2016)

The Baerveldt Glaucoma Drainage Device: Efficacy, Safety, and Place in Therapy
por: Poelman, Huub J, et al.
Publicado: (2020)

Rituximab-Related Reversible Hepatocellular Damage
por: Toprak, Selami K., et al.
Publicado: (2012)

Acute painful lumbosacral paresthesia after intrathecal rituximab
por: Bromberg, J. E. C., et al.
Publicado: (2011)

Infectious Risks and Optimal Strength of Maintenance Immunosuppressants in Rituximab-Treated Kidney Transplantation
por: Baek, Chung Hee, et al.
Publicado: (2012)

Bilateral infectious scleritis from Histoplasma capsulatum in an immunosuppressed uveitis patient
por: Wang, Kevin, et al.
Publicado: (2021)

Effectiveness of pharmacological agents for the treatment of non-infectious scleritis: a systematic review protocol
por: Ingaralingam, Sathana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r27d2t13uqgaco412tsoell9pk